Literature DB >> 32529379

Poor Insight in Schizophrenia Patients in China: a Meta-Analysis of Observational Studies.

Wen Li1, Hong-He Zhang2, Yu Wang3, Ling Zhang4, Gabor S Ungvari5,6, Teris Cheung7, Yu-Tao Xiang8.   

Abstract

Poor insight exists in all phases of schizophrenia and is associated with poor clinical prognosis and adverse psychosocial functioning. This is a meta-analysis examining the prevalence of poor insight and its correlates in Chinese patients with schizophrenia. Both major international (PubMed, EMBASE, PsycINFO, and Web of Science) and Chinese (WANFANG and CNKI) databases were systematically searched. The pooled prevalence of poor insight was calculated using the random-effects model. A total of 19 studies with 3112 schizophrenia patients were included. The prevalence of poor insight was 43.4% (95%CI: 36.0%-51.2%). Subgroup and meta-regression analyses revealed that the higher prevalence of poor insight was significantly associated with single-site design, smaller sample size, inpatient status, acute illness phase, higher male proportion, younger age, shorter duration of illness, lower study quality, and earlier publication year. Poor insight is common in Chinese schizophrenia patients. Considering the negative outcomes of poor insight, regular screening and effective psychosocial interventions should be delivered for this vulnerable population.

Entities:  

Keywords:  Meta-analysis; Poor insight; Prevalence; Schizophrenia

Year:  2020        PMID: 32529379     DOI: 10.1007/s11126-020-09786-7

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  5 in total

1.  Co-occurring Deficits in Clinical and Cognitive Insight in Prolonged Schizophrenia-Spectrum Disorders: Relationship to Metacognitive Deficits.

Authors:  Joshua E Mervis; Kelsey A Bonfils; Samuel E Cooper; Courtney Wiesepape; Paul H Lysaker
Journal:  Schizophr Bull Open       Date:  2021-07-20

2.  Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C]DASB.

Authors:  Jeong-Hee Kim; Young-Don Son; Hang-Keun Kim; Jong-Hoon Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2021-10-21       Impact factor: 2.570

3.  Similarities and Differences in Brain Activation Between Patients With Schizophrenia and Obsessive-Compulsive Disorder: A Near-Infrared Spectroscopy Study.

Authors:  Xiaoyu Fu; Wenxiang Quan; Lijun Liu; Tian Li; Wentian Dong; Jiuju Wang; Ju Tian; Jun Yan; Jinmin Liao
Journal:  Front Psychiatry       Date:  2022-04-26       Impact factor: 4.157

4.  Quality of life in patients with schizophrenia: A 2-year cohort study in primary mental health care in rural China.

Authors:  Xiao-Yan He; Christine Migliorini; Zhuo-Hui Huang; Fei Wang; Rui Zhou; Zi-Lang Chen; Yao-Nan Xiao; Qian-Wen Wang; Shi-Bin Wang; Carol Harvey; Cai-Lan Hou
Journal:  Front Public Health       Date:  2022-09-07

5.  Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan.

Authors:  Yun Tien; Hsiang-Ping Huang; Ding-Lieh Liao; Shang-Chien Huang
Journal:  Ther Adv Psychopharmacol       Date:  2022-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.